2[1]Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance. 1994-1997. World Health Organization-International Union against Taberculosis and Lung disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance[J]. N Engl J Med, 1998,338:1641-1649
3[2]Lambregts-van Weezenbeek KS, Reichman LB. DOTS and DOTS-PLUS: What's in a name[J]. Int J Tuberc Lung Dis,2000,4: 995-996
4[3]Bastan I, Colebunders R. Treatment and prevention of multidrugresistant tuberculosis[J]. Drugs, 1999,58 :633-661
5[4]WHO-IUATLD Globe Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world, report no. 2: prevalence and trends[R]. Geneva: WHO,2000
6[5]World Health Organization. Global tuberculosis control[R].WHO report 2000. Genera:WHO,2000
7[6]Dye C, Scheele S, Dolin P, et al. Global burden of tuberculosis:estimated incidence, prevalence, and mortality by country [ J].JAMA, 1999,282 : 677-686
8[7]Isman MD. TB elimination in the 21st century, a quixotic dream? [J] Int J Tuberc Lung Dis, 2000,4(12 Suppl 2):s109-s110
9[9]Fang Z, Doig C, Rayner A, et al. Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland(1990 to 1997)[J]. J Clin Microbiol, 1999,37:998-1003
10[10]Kiepiela P,Bishop KS, Smith AN, et al. Genomic mutations in the katG,inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa[J]. Tuver Lung Dis, 2000, 80:47-56
4World Health Organization.WHO Report "2001 Global Tuberculosis Control"[ R ].Geneva:WHO.2001.
5Alex van Belkum. Tracing isolates of bacterial species by multilocus variable number of tandem repeat analysis [J]. Immunol Med Microbiol, 49 (2007): 22-27.
6DeRiemer K, GarcIa2GarcIa L, Bobadilla2del2Valle M, et al. Does DOTS work in populations with drug2resistant tuberculosis [J]. Lancet, 2005 , 365: 1239-1245.
7Durmaz R, Ozerol IH, DunnazB, et al. Primary drug resistance and molecular ep idemiology of Mycobacterium tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey[J], Microb Drug Resist, 2003, 9: 361-366.
